SAR by Space: Enriching Hit Sets from the Chemical Space.
Binding Sites
Computational Biology
/ methods
Databases, Chemical
Drug Evaluation, Preclinical
/ methods
High-Throughput Screening Assays
Humans
Inhibitory Concentration 50
Molecular Docking Simulation
Molecular Structure
Protein Binding
Small Molecule Libraries
/ chemistry
Structure-Activity Relationship
Transcription Factors
/ chemistry
BRD4 inhibitors
bromodomains
chemical space
new chemical entities
Journal
Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009
Informations de publication
Date de publication:
26 Aug 2019
26 Aug 2019
Historique:
received:
26
07
2019
revised:
14
08
2019
accepted:
23
08
2019
entrez:
29
8
2019
pubmed:
29
8
2019
medline:
22
1
2020
Statut:
epublish
Résumé
We introduce SAR-by-Space, a concept to drastically accelerate structure-activity relationship (SAR) elucidation by synthesizing neighboring compounds that originate from vast chemical spaces. The space navigation is accomplished within minutes on affordable standard computer hardware using a tree-based molecule descriptor and dynamic programming. Maximizing the synthetic accessibility of the results from the computer is achieved by applying a careful selection of building blocks in combination with suitably chosen reactions; a decade of in-house quality control shows that this is a crucial part in the process. The REAL Space is the largest chemical space of commercially available compounds, counting 11 billion molecules as of today. It was used to mine actives against bromodomain 4 (BRD4). Before synthesis, compounds were docked into the binding site using a scoring function, which incorporates intrinsic desolvation terms, thus avoiding time-consuming simulations. Five micromolecular hits have been identified and verified within less than six weeks, including the measurement of IC50 values. We conclude that this procedure is a substantial time-saver, accelerating both ligand- and structure-based approaches in hit generation and lead optimization stages.
Identifiants
pubmed: 31454992
pii: molecules24173096
doi: 10.3390/molecules24173096
pmc: PMC6749418
pii:
doi:
Substances chimiques
Small Molecule Libraries
0
Transcription Factors
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Déclaration de conflit d'intérêts
The work herein is a joint collaboration between Enamine or BioSolveIT of which some of the authors are employees; the chemical space navigation software is available for free for testing but commercially available for longer term usage from BioSolveIT. Enamine offers the compounds for purchase. The funding parties had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.
Références
J Comput Aided Mol Des. 2001 Jun;15(6):497-520
pubmed: 11495223
Anal Biochem. 2004 Sep 1;332(1):153-9
pubmed: 15301960
Biochemistry. 2005 Apr 5;44(13):5258-66
pubmed: 15794662
Nat Protoc. 2007;2(9):2212-21
pubmed: 17853878
ChemMedChem. 2008 Jun;3(6):885-97
pubmed: 18384086
Nature. 2010 Dec 23;468(7327):1067-73
pubmed: 20871596
J Chem Inf Model. 2011 Dec 27;51(12):3199-207
pubmed: 22067015
J Comput Aided Mol Des. 2012 Jun;26(6):701-23
pubmed: 22203423
PLoS Comput Biol. 2012;8(2):e1002380
pubmed: 22359493
J Chem Inf Model. 2012 Jul 23;52(7):1757-68
pubmed: 22587354
ACS Comb Sci. 2012 Nov 12;14(11):579-89
pubmed: 23020747
ChemMedChem. 2013 Oct;8(10):1690-700
pubmed: 23929679
ACS Chem Biol. 2014 May 16;9(5):1160-71
pubmed: 24568369
J Cheminform. 2014 Apr 03;6:12
pubmed: 24694216
Nat Rev Drug Discov. 2014 May;13(5):337-56
pubmed: 24751816
Acc Chem Res. 2015 Mar 17;48(3):722-30
pubmed: 25687211
J Chem Inf Model. 2015 May 26;55(5):915-24
pubmed: 25894297
J Med Chem. 2016 Feb 25;59(4):1271-98
pubmed: 26572217
J Chem Inf Model. 2016 Jul 25;56(7):1253-66
pubmed: 27286472
J Med Chem. 2016 Sep 8;59(17):7801-17
pubmed: 27528113
Nucleic Acids Res. 2017 Jan 4;45(D1):D158-D169
pubmed: 27899622
J Med Chem. 2017 Jun 8;60(11):4533-4558
pubmed: 28195723
Chem Rev. 2018 Feb 14;118(3):1216-1252
pubmed: 29405707
Eur J Med Chem. 2018 May 10;151:450-461
pubmed: 29649741
Bioorg Med Chem. 2018 Jul 23;26(12):3399-3405
pubmed: 29764756
J Med Chem. 2019 Feb 14;62(3):1116-1124
pubmed: 30148631
Mol Cancer. 2018 Nov 22;17(1):164
pubmed: 30466442
Medchemcomm. 2018 Aug 7;9(11):1779-1802
pubmed: 30542529
Nature. 2019 Feb;566(7743):224-229
pubmed: 30728502
Drug Discov Today. 2019 May;24(5):1148-1156
pubmed: 30851414
Proc Natl Acad Sci U S A. 2019 Jun 4;116(23):11496-11501
pubmed: 31113876
Nat Rev Drug Discov. 2019 Aug;18(8):609-628
pubmed: 31273347
Med Res Rev. 1996 Jan;16(1):3-50
pubmed: 8788213
J Comput Aided Mol Des. 1998 Sep;12(5):471-90
pubmed: 9834908